Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: INTESTIFIX 001-placebo ×

INTESTIFIX 001-placebo

This drug is selected. Its supporting articles are shown below.

INTESTIFIX 001-placebo1

Articles mentioning INTESTIFIX 001-placebo

1 articles · page 1 of 1

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

bmjopen · abstract · 2025-09-09 · 1 matching annotations

97.0%

INTESTIFIX 001-placebo INTESTIFIX 001 sorafenib vancomycin atezolizumab vancomycin-placebo A/B bevacizumab melanoma HCC

…in, A/B+INTESTIFIX 001 in comparison to vancomycin-placebo, A/B+INTESTIFIX 001-placebo and safety of the therapeutic combination in advanced HCC. INTE…

Browse drugs

INTESTIFIX 001-placebo

Articles mentioning INTESTIFIX 001-placebo

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)